We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Esperion Therapeutics Inc | NASDAQ:ESPR | NASDAQ | Common Stock |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
2.09 | 2.14 | 2.12 | 2.03 | 2.12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 116.33M | -209.25M | -1.1307 | -1.82 | 381.21M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
00:59:46 | formt | 100 | 2.10 | USD |
Date | Time | Source | Headline |
---|---|---|---|
13/12/2023 | 21:46 | DJN | Esperion Therapeutics' Nexletol, Nexlizet Updates Get FDA Approval |
Esperion Therapeutics (ESPR) Share Charts1 Year Esperion Therapeutics Chart |
|
1 Month Esperion Therapeutics Chart |
Intraday Esperion Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions